CoChat

Deferoxamine delays the development of the hepatotoxicity of acetaminophen in mice

The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.

Abstract

The hepatotoxicity of acetaminophen is conventionally ascribed to metabolism by CYP450 to N-acetyl-p-benzoquinone imine and covalent binding to proteins. We investigated a potential role for oxidative stress by determining the effect of the ferric chelator deferoxamine (Desferal) on acetaminophen (paracetamol)-induced hepatotoxicity in mice. Administration of deferoxamine (75 mg/kg) 1 h after a toxic dose of acetaminophen (300 mg/kg) significantly delayed the development of the toxicity without altering covalent binding. In saline-treated mice serum ALT was 18 +/- 2 IU/l. In acetaminophen-treated mice serum alanine aminotransferase (ALT) was 779 +/- 271 at 2 h, 7421 +/- 552 IU/l at 4 h, 5732 +/- 523 IU/l at 8 h, and 5984 +/- 497 IU/l at 24 h. In acetaminophen plus deferoxamine-treated mice, serum ALT was 80 +/- 10 at 2 h, 472 +/- 74 IU/l at 4 h, 2149 +/- 597 IU/l at 8 h, and 5766 +/- 388 at 24 h. Deferoxamine at 1 h after acetaminophen did not decrease serum ALT at 12 h; however, deferoxamine at 1 and 4 h, or deferoxamine at 1 h plus N-acetylcysteine at 4 h to replete hepatic glutathione, decreased the toxicity from 5625 +/- 310 IU/l to 3436 +/- 546 IU/l and 3003 +/- 282 IU/l, respectively. Deferoxamine plus N-acetylcysteine at 1.25 h after acetaminophen was more effective at decreasing the 24 h toxicity than N-acetylcysteine alone. In acetaminophen treated mice, higher doses of deferoxamine (150-300 mg/kg) at 1 h greatly increased the observed hepatotoxicity at 4 h in a dose responsive manner, but deferoxamine alone was nontoxic.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0378-4274(99)00021-1

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 44 references

Cited by

See all 68

Metadata

Authors
Schnellmann, J. G., Pumford, N. R., Kusewitt, D. F., Bucci, T. J., & Hinson, J. A.
Affiliations
  • University of Arkansas for Medical Sciences (US)
  • National Center for Toxicological Research (US)
Corresponding author
Hinson, Jack A.
Venue
Toxicology Letters
Publisher
Elsevier BV
Published
1999-05
Volume
106
Issue
1
Pages
79-88
ISSN
0378-4274 (ISSN-L)
OpenAlex
W2025344040
Cited by
68
References
46
Citations by year
2026: 1 · 2025: 4 · 2024: 5 · 2023: 3 · 2022: 1 · 2021: 5 · 2020: 4 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 3 · 2015: 1 · 2014: 3 · 2013: 3 · 2012: 1
FWCI
1.54
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Toxicology Letters (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01gm048749-04)
  • National Institute of General Medical Sciences (GM-48749)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Paraquat toxicity studies and treatments
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords
deferoxamine, acetaminophen hepatotoxicity, oxidative stress, N-acetylcysteine, glutathione, alanine aminotransferase, N-acetyl-p-benzoquinone imine, covalent protein binding, dose-response relationship, hepatoprotection
MeSH terms
Acetaminophen, Acetylcysteine, Animals, Chelating Agents, Deferoxamine, Dose-Response Relationship, Drug, Kupffer Cells, Liver, Male, Analgesics, Non-Narcotic, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Deferoxamine delays the development of the hepatotoxicity of acetaminophen in mice. https://app.cochat.ai/papers/10.1016/s0378-4274(99)00021-1
The paper
Schnellmann, J. G., Pumford, N. R., Kusewitt, D. F., Bucci, T. J., & Hinson, J. A. (1999). Deferoxamine delays the development of the hepatotoxicity of acetaminophen in mice. Toxicology Letters. https://doi.org/10.1016/s0378-4274(99)00021-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.